Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001372948 | SCV001569644 | uncertain significance | Developmental and epileptic encephalopathy, 9 | 2020-10-09 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PCDH19 protein function. This variant has not been reported in the literature in individuals with PCDH19-related conditions. This variant is present in population databases (rs774791898, ExAC 0.01%). This sequence change replaces valine with leucine at codon 1081 of the PCDH19 protein (p.Val1081Leu). The valine residue is weakly conserved and there is a small physicochemical difference between valine and leucine. |
Gene |
RCV001762650 | SCV001990616 | uncertain significance | not provided | 2019-04-03 | criteria provided, single submitter | clinical testing | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |